Servier's VORANIGO® (vorasidenib) Receives Prestigious 2025 Prix Galien USA Award
PR Newswire —
BOSTON, Oct. 31, 2025 /PRNewswire/ -- Servier today announced that VORANIGO® (vorasidenib) has been awarded The Galien Foundation's 2025 Prix Galien USA Award for Best Product for Orphan/Rare Disease. The award was presented during a ceremony at the American Museum of Natural History in...
 
       
             
             
             
             
             
             
             
             
             
             
            